SBIO ALPS Medical Breakthroughs ETF

Seeks to track, before fees and expenses, the Poliwogg Medical Breakthroughs Index. The Index is a portfolio of small and mid-cap biotechnology and pharmaceutical stocks listed on US stock exchanges that have one or more drugs in either Phase II or Phase III US FDA clinical trials. The Index includes stocks of mid cap and small cap companies with a market capitalization of no less than $200 million and no more than $5 billion.

$26.45  +0.30 (1.16%)
As of 05/16/2022 15:22:08 EST     IEX book   CBOE book

---

ETF Information

---

Sponsor:     ALPS
Category1:  US Equity
Category2:  Single industry
Category3:  Biotechnology
Morningstar category:  Health
Leverage factor:  1.00
Inception date:  12/30/2014
Index tracking method: Passive replication
Current yield:  0.00%
Historical average yield:  0.54%
Market cap:  $90,786,098
Average volume:  38,779
Fees:     0.5000%

---

Index Information

---

Poliwogg Medical Breakthroughs Index
Index symbol:  PMBI
Provider:   S-Network Global Indexes
Index weighting:   Market capitalization
Index inception date:  01/27/2006
Backtesting data exists:   No
Number of holdings:  90  (as of 09/15/2017)